Director - Mass Spectrometry-based Biomarker Discovery - Neuroscience

Director - Mass Spectrometry-based Biomarker Discovery - Neuroscience

Join Lilly, a global healthcare leader headquartered in Indianapolis, Indiana, dedicated to improving life for people worldwide. We are seeking a visionary leader with deep expertise in mass‑spectrometry‑based biomarker discovery and validation to spearhead our neuroscience portfolio.

The successful candidate will develop and validate novel assays for early‑ and late‑phase clinical trials in neurodegenerative diseases, including Alzheimer’s, Parkinson’s, ALS, and other rare brain disorders. You will mentor junior associates, collaborate with cross‑functional teams, and drive assay development from concept through clinical integration.

Key Responsibilities

• Design, develop, and validate novel mass‑spectrometry‑based biomarker assays for preclinical and clinical studies.
• Mentor junior scientists to execute in‑vitro experiments supporting therapeutic molecule characterization.
• Plan and oversee method development, optimization, and sample analyses with internal and external partners.
• Implement rigorous assay validation procedures for high‑performance biomarker assays.
• Serve as the scientific and technical expert for in‑house and outsourced biomarker discovery efforts.
• Collaborate with medical, operations, statistics, regulatory, CROs, and academic partners to integrate biomarker validation into clinical programs.
• Communicate findings through presentations, publications, and strategic discussions.

Basic Qualifications

Additional Skills / Preferences

Compensation : $184,500 – $321,200 (annual base). Full‑time position with comprehensive benefits.

Lilly is an equal‑employment‑opportunity employer and does not discriminate on the basis of age, race, color, religion, gender identity, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or other legally protected status.

#J-18808-Ljbffr